Congenital Heart Disease Physical Activity Lifestyle Study V.2
The Congenital Heart Disease Physical Activity Lifestyle Intervention Study (CHD-PALS) V.2 seeks to determine the efficacy of a lifestyle intervention program for adolescents and young adults (AYAs) with congenital heart disease (CHD). This trial was adapted from the original CHD-PAL trial to continue improving cardiov
| Condition(s) | Heart Defects, Congenital, Cardiovascular Disease Other |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The Congenital Heart Disease Physical Activity Lifestyle Intervention Study (CHD-PALS) V.2 seeks to determine the efficacy of a lifestyle intervention program for adolescents and young adults (AYAs) with congenital heart disease (CHD). This trial was adapted from the original CHD-PAL trial to continue improving cardiovascular outcomes for transition-aged CHD survivors. |
| Who can participate | Inclusion Criteria: * Between the ages of 15-25 years * Diagnosed with moderate or complex structural CHD * Actively receiving care from a cardiologist at Nationwide Children's Hospital (NCH) or Ohio State University (OSU) Exclusion Criteria: * Unable to speak and read proficiently in English * Have a diagnosis of a genetic syndrome that impacts multiple organ systems * Have cognitive impairments that would interfere with completing study measures * Have been engaged in a formal exercise program within the past 6 months, * Have participated in the intervention arm of the previous CHD-PAL Study * Have undergone open-heart surgery or had a valve replacement in the last 3 months * Are unable to complete an exercise stress test using a treadmill * Are pregnant * Are prohibited to engage in at |
| Ages | 15 Years to 25 Years |
| Sex | All |
| Lead sponsor | Jamie Jackson |
| Locations | Columbus, Ohio, United States |
| Start date | 2023-07-18 |
| NCT ID | NCT06003023 |
| Official listing | https://clinicaltrials.gov/study/NCT06003023 |